Showing results (21-30 of 54) with videos related to
Sort By:
Pageof 6
Hamostaseologie|May 9, 2003
[Chromogenic substrate as antidote against the thrombin inhibitor Melagatran?]I Bodendiek, S Lentz, M Seeger, et al.Angiology|June 1, 1989
Importance of blood viscoelasticity in arteriosclerosisK M Hell, A Balzereit, U Diebold, et al.Oncology|January 1, 1990
Investigations of coagulation system and fibrinolysis in patients with disseminated adenocarcinomas and non-Hodgkin's lymphomasK H Zurborn, H Duscha, J Gram, et al.Deutsche Medizinische Wochenschrift (1946)|July 5, 1996
[The thrombophilic status of patients with inflammatory diseases]M Lins, K H Zurborn, B Pries, et al.Scandinavian Journal of Gastroenterology|November 1, 1991
Increased levels of fibrinolysis reaction products (D-dimer) in patients with decompensated alcoholic liver cirrhosisJ Gram, H Duscha, K H Zurborn, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1991
Fibrinogen Kiel: a congenital dysfibrinogenaemia with (A alpha-16 Arg----His) substitution characterized by HPLC without prior isolation of fibrinogenH H Seydewitz, J Gram, H D Bruhn, et al.Deutsche Medizinische Wochenschrift (1946)|September 21, 1979
[Does low-dosage heparin treatment require serial haematological controls? (author's transl)]H D Bruhn, J P Albert, L Sachs, et al.Klinische Wochenschrift|February 15, 1983
Influences of thrombin, factor XIII and fibronectin on the growth of tumor cells and leukemic cells in vitroH D Bruhn, R Bernsmeier, P Lück, et al.Onkologie|February 1, 1983
[Thrombin, factor XIII and fibronectin as regulators of the proliferation of tumor cells and vascular wall cells]R Bernsmeier, E Holzgrebe, P Lück, et al.Diabetes, Obesity & Metabolism|January 5, 2011
Patient perspectives on once-weekly medications for diabetesW H Polonsky, L Fisher, D Hessler, et al.Pageof 6